
IMU is a discovery engine mapping the immune system to advance precision medicine.

IMU is a discovery engine mapping the immune system to advance precision medicine.
What they do: Multi-omic, high-resolution immune-profiling platform (CytAtlas / IMU) with AI analytics for precision medicine
Founded: 2021
Headquarters / Industry: London / Biotechnology Research
Recent funding: Series A announced Jan 24, 2024 (led by Molten Ventures)
| Company |
|---|
Decoding the human immune system to enable precision medicine applications (diagnostics, monitoring, drug discovery and treatment-response prediction).
2021
Biotechnology Research
£11.5M
Announced close of Series A financing; reported as £11.5M
Earlier venture round listed with Beaumont Capital
“Led by Molten Ventures in Series A; earlier investor participation includes Beaumont Capital and Life Extension Ventures”
About the job
The immune system is a fundamental determinant of human health, governing resilience to infection and shaping susceptibility to disease and response to treatment. Advances in our understanding of immune function have catalysed some of the most transformative breakthroughs in modern medicine, underpinning a new era of immunotherapies and immune-based interventions.
At IMU Biosciences, our mission is to decode the immune system at unprecedented resolution and translate these insights into meaningful clinical impact. By redefining immune measurement and interpretation at scale, we aim to advance precision medicine, develop diagnostics that enable earlier and more targeted intervention, and unlock novel strategies to harness immunity for the prevention and treatment of disease.
We are a multidisciplinary team of scientists, software engineers and statisticians united by a shared ambition: to change the future of medicine through the power of immune data. We value diversity of thought, creativity, initiative, and a willingness to tackle hard problems in new ways. As an early-stage startup with state-of-the-art laboratories in central London, this is an exciting time to join IMU as we scale our platform and grow our team.
As a Scientist I at IMU Biosciences, you will be embedded in the wet lab platform team and work closely with other scientists to generate high-quality, reproducible data, providing a new perspective on human immunology. You will be responsible for the day-to-day operation of the next-gen spectral flow and single cell genomics IMU platform.
Job description
We are seeking a highly motivated, enthusiastic, dedicated and collaborative scientist to join IMU. The successful candidate will be involved in conducting and helping to develop state of the art immune phenotyping assays on human blood and tissue samples from a variety of sources and will need to be comfortable working autonomously but also have excellent interpersonal skills to work as part of the team. Experience in relevant laboratory techniques including the isolation of blood immune cells and flow cytometry are essential. Relevant training and guidance will be provided by our team.
Our laboratory is situated in our head office in Canary Wharf. In this role you will need to be working at the lab/office in-person every weekday, during typical working hours.
Responsibilities
Day to day responsibilities
Supporting responsibilities
Continuous improvement and innovation of our practices
The above list of responsibilities may not be exhaustive, and the post holder will be required to undertake such tasks and responsibilities as may reasonably be expected within the scope, purpose and grading of the post.
Skills, knowledge and experience
Essential Criteria
Desirable Criteria
Benefits
How to apply
Please apply directly on LinkedIn or send CV and cover letter to Jennie Yang (jennie@imubiosciences.com)
Office/lab location = 20 Water Street, Canary Wharf, E14 5GX, UK.